About Sonic Incytes
Sonic Incytes is a company based in Vancouver (Canada) founded in 2016.. Sonic Incytes has raised $9.84 million across 2 funding rounds from investors including The University of British Columbia, E-Fund and Worldchanging Ventures. Sonic Incytes offers products and services including Velacur Device and Velacur Procedure. Sonic Incytes operates in a competitive market with competitors including Butterfly Network, Exo, SonoSite, Zonare Medical Systems and TechsoMed, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sonic Incytes Medical Corp.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.84 M (USD)
in 2 rounds
-
Latest Funding Round
$7.3 M (USD), Series A
Dec 07, 2021
-
Investors
The University of British Columbia
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sonic Incytes
Sonic Incytes offers a comprehensive portfolio of products and services, including Velacur Device and Velacur Procedure. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-guided tool for non-invasive liver stiffness and fat fraction measurement.
Three-step process for real-time liver assessment in clinical settings.
Unlock access to complete
Funding Insights of Sonic Incytes
Sonic Incytes has successfully raised a total of $9.84M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7.3 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $7.3M
-
First Round
First Round
(29 May 2020)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series A - Sonic Incytes | Valuation | Nimbus Synergies | |
| May, 2020 | Amount | Seed - Sonic Incytes | Valuation | Genome British Columbia |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sonic Incytes
Sonic Incytes has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include The University of British Columbia, E-Fund and Worldchanging Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on early-stage health tech companies
|
Founded Year | Domain | Location | |
|
MEDTEQ+ is focused on accelerating health technology innovation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sonic Incytes
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sonic Incytes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sonic Incytes Comparisons
Competitors of Sonic Incytes
Sonic Incytes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, SonoSite, Zonare Medical Systems and TechsoMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| domain | founded_year | HQ Location |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| domain | founded_year | HQ Location |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| domain | founded_year | HQ Location |
Portable ultrasound systems are developed and provided for medical use.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
|
| domain | founded_year | HQ Location |
UV-C disinfection systems for ultrasound probes are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sonic Incytes
Frequently Asked Questions about Sonic Incytes
When was Sonic Incytes founded?
Sonic Incytes was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Where is Sonic Incytes located?
Sonic Incytes is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Who is the current CEO of Sonic Incytes?
George Aliphtiras is the current CEO of Sonic Incytes.
Is Sonic Incytes a funded company?
Sonic Incytes is a funded company, having raised a total of $9.84M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.54M, raised on May 29, 2020.
What does Sonic Incytes do?
Founded in 2016 in Vancouver, Canada, operations focus on the medical technology sector. Point-of-care ultrasound diagnostic devices are developed, including Velacur for detecting and managing liver diseases linked to metabolic syndrome. Clinical data is tracked through an AI-supported platform that assists healthcare professionals in diagnosis and treatment planning.
Who are the top competitors of Sonic Incytes?
Sonic Incytes's top competitors include Butterfly Network, Exo and TechsoMed.
What products or services does Sonic Incytes offer?
Sonic Incytes offers Velacur Device and Velacur Procedure.
Who are Sonic Incytes's investors?
Sonic Incytes has 14 investors. Key investors include The University of British Columbia, E-Fund, Worldchanging Ventures, Nimbus Synergies, and Nicola Wealth.